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Letter to the Editor 
RESPONSE TO THE REPORT BY DREXLER ET AL. 
Dear Editor: 
In their report, Drexler et ah took the pretext of our recent pub- 
lication (Suda et al., 2001) to make some fundamental statements 
on the danger of cross-contamination between cell lines. We fully 
agree with their analysis. It is a fact that even cell lines from cell 
banks do not automatically guarantee the identity of the ceils as 
has been recently demonstrated with the ECV304 cell line. With 
the advent of the genotype fingerprinting, it can be expected that 
in the near future the identity of cells from cell line banks will be 
checked and certified. 
In our publication we clearly state from the beginning that fin- 
gerprinting has revealed the genotypieal identity of ECV304 with 
the T24 bladder carcinoma cell line (Dirks et al., 1999). The aim 
of our study originally was to establish a blood-brain barrier (BBB) 
model for permeation studies screening different cell lines, one of 
them being the ECV304 (acquired irectly from the American Type 
Culture Collection [ATCC]). As it stands, no cell culture system of 
endothelial origin is available for Ussing chamber-type permeation 
studies, which rely on the fommtion of tight monolayers of the cells 
under investigation. Neither primary cultures of the rat brain en- 
dothelial cells nor PBMEC/C1-2, a porcine brain microvaseular en- 
dothelial cell line (Teifel and Friedl, 1996), form tight monolayers 
as judged by transendothelial electrical resistance (TEER) mea- 
surements and permeation studies with mannitol (Snda et al., 2001). 
This is the reason that before the identification of ECV304 as a 
cross-contaminant, these monolayer-forming cells with high TEER 
values were widely used as a BBB model. Different suggestions have 
been made during the ongoing discussion regarding relevant BBB 
models for pemmation studies in which the tightness of the cell 
layer plays a fundamental role. In this context, even the use of the 
well-characterized Madin-Darby canine kidney (MDCK) (MeRoberts 
et al., 1981) has been proposed (Veronesi, 1996), despite its epi- 
thelial origin, on the basis of its high electrical resistance. Seen in 
this background, we found it appropriate to present a phenotypieal 
comparison of ECV304 and the authentic T24 cell line with a typ- 
ical endothelial cell line (PBMEC/C1-2) and a typical epithelial 
cell line (MDCK) (Suda et al., 2001). It is iinportant o note that 
phenotypical differences between ECV304 cells from different 
sources, namely, the ATCC and the ECACC, have previously been 
reported (Scism et al., 1999). This may" explain the discrepancies 
to our results pointed out by Drexler et al., who did not specify the 
source of the cells used for their unpublished results mentioned in 
their report. In summary, it is up to every researcher to make the 
choice of adequate xperimental systems under the conditions that 
it is well defined and declared. 
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